10 results
8-K
EX-99.2
AXSM
Axsome Therapeutics Inc
7 Dec 23
Other Events
4:05pm
(65.5) 43 (72.9) Black or African American 4 (13.3) 8 (27.6) 12 (20.3) Asian 1 (3.3) 2 (6.9) 3 (5.1) Unknown 1 (3.3) 0 1 (1.7) Body mass index (kg/m2
8-K
EX-99.2
zvckzo5k3a 4d
27 Apr 20
Axsome Therapeutics Announces AXS-05 Achieves Primary Endpoint in the ADVANCE-1 Pivotal Phase 2/3 Trial in Alzheimer’s Disease Agitation
8:00am
8-K
EX-99.2
pauyk6az6n14357693
6 Apr 20
Other Events
8:18am
8-K
EX-99.2
llp9zlzeb3oiks
30 Mar 20
Other Events
9:47am
8-K
EX-99.2
yxa8x2
30 Dec 19
Other Events
8:15am
8-K
EX-99.2
uyxgzgn2
16 Dec 19
Axsome Therapeutics Announces AXS-05 Achieves Primary Endpoint in GEMINI Phase 3 Trial in Major Depressive Disorder
8:25am
- Prev
- 1
- Next